Annovis Bio, Inc.

NYSE:ANVS

4.37 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 0000000
Cost of Revenue 0000000
Gross Profit 0000000
Gross Profit Ratio 0000000
Reseach & Development Expenses 38.79116.5168.4793.0540.7760.1120.273
General & Administrative Expenses 6.2448.9966.0583.5860.8290.6020.409
Selling & Marketing Expenses 0000000
SG&A 6.2448.9966.0583.5860.8290.6020.409
Other Expenses 00-0.037-1.157-0.73500
Operating Expenses 45.03525.51114.55.4830.8710.7140.682
Operating Income -45.035-25.511-14.537-6.64-1.606-0.714-0.682
Operating Income Ratio 0000000
Total Other Income Expenses Net -11.1690.1830.051.1780.61500
Income Before Tax -56.204-25.329-14.487-5.462-0.991-0.714-0.682
Income Before Tax Ratio 0000000
Income Tax Expense 0-0.183-0.05-1.205-0.694-0-0.682
Net Income -56.204-25.146-14.437-4.257-0.297-0.714-0.682
Net Income Ratio 0000000
EPS -6.23-3.08-1.89-0.67-0.066-0.16-0.16
EPS Diluted -6.23-3.08-1.89-0.67-0.066-0.16-0.16
EBITDA -45.035000000
EBITDA Ratio 0000000